Veriheal

APRIL 7, 2022

While cannabis’ potential to assist with MS has been known for some time now, it’s important to bolster previous findings with expansive research. The researchers suggest that the cannabinoids in MMJ can assist with the treatment of MS, contributing “add-on immunosuppressive, analgesic, neuroprotective and remyelinative effects.”

Patients 98

Patients Treatment Cannabinoids Pharmaceutical 98

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

JUNE 17, 2021

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. regulatory approval, and our new cannabinoid research platform,” said Renée Galá, the chief financial officer of Jazz Pharmaceuticals.

Pharmaceutical 108

Pharmaceutical Clinical Trials Therapy Programs 108

Veriheal

FEBRUARY 21, 2023

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. How Do MMJ Restrictions Affect Patients and Doctors? Many patients take MMJ for more reasons than one.

Access 98

Access Patients Chronic Pain Conditions 98

United Patients Group

FEBRUARY 7, 2023

Benefits of Cannabis for Inflammation and Pain Introduction Inflammation and pain are two of the most common health issues that many people face. Cannabis has been used as medicine for thousands of years, and there are many different ways this plant can help with inflammation and pain relief by interacting with our bodies in different ways.

Cannabinoids 114

Cannabinoids Chronic Pain Terpenes THC 114

Cannabis Law Report

FEBRUARY 1, 2022

New softgel capsule products further expand ZYUS’ medical cannabinoid offerings and provide patients a precise method for dosing. The launch of these two new softgel products marks another important milestone in ZYUS’ mission to elevate cannabinoids as a standard of care and leverage their transformational potential.

Cannabinoids 52

Cannabinoids Patients Research and Development Media 52

Canna Care Docs

OCTOBER 3, 2023

On top of overwhelming struggles or feelings, patients who have been diagnosed with a terminal illness can face a broad range of both physical and psychological effects. However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Cannabis Law Report

NOVEMBER 17, 2021

Launch of Zylem ™ 20:1 further expands ZYUS product offerings with new cannabinoid formulation. The launch of this formulation marks an important milestone in ZYUS’ mission to elevate cannabinoids as a standard of care and leverage their transformational potential. About ZYUS Life Sciences Inc. Visit www.zyus.com.

Cannabinoids 52

Cannabinoids Patients Research and Development Extraction 52

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. InMed has conducted preclinical pharmacology studies that suggest CBN in INM-755 may help relieve hallmark EB symptoms, including inflammation and pain, as well potentially restore the integrity of the skin in a subset of EB Simplex patients. For more information, visit www.inmedpharma.com.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Leafwell

JANUARY 15, 2021

This article is for medical marijuana patients and physicians alike. We believe knowledge is power and Leafwell seeks to educate not only patients but medical professionals as well.

Pharmaceutical 117

Pharmaceutical Education Cannabinoids Patients 117

Leafwell

JANUARY 15, 2021

This article is for medical marijuana patients and physicians alike. We believe knowledge is power and Leafwell seeks to educate not only patients but medical professionals as well.

Pharmaceutical 117

Pharmaceutical Education Cannabinoids Patients 117

Veriheal

JANUARY 26, 2023

According to recent research, cannabis could offer unique benefits as part of an approach to managing bipolar disorder. In this article, we’ll explore how the potential advantages of cannabis might help stabilize symptoms associated with bipolar disorder. Most commonly, pharmaceutical medication is prescribed to regulate moods.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

SpeedWeed

AUGUST 8, 2021

It’s the first cannabis-derived pharmaceutical to be legalized in many countries around the world, including the UK, Spain, United States, Canada, and New Zealand. . If all goes according to plan, patients will receive Sativex and the temozolomide chemotherapy drug, temozolomide on its own, or a placebo.

Cannabinoids 64

Cannabinoids Pharmaceutical DEA Medicine 64

The Cannigma

JUNE 2, 2022

Ever wondered how cannabinoids like THC or CBD affect your blood? It may seem like a weird question, but it is a vitally important one for anyone taking anticoagulant medications and considering using cannabis. The short answer is – no, in most cases cannabinoids do not seem to act as strong blood thinners.

Blood Pressure 112

Blood Pressure Cannabinoids Patients THC 112

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. Medical cannabis costs family £4,000 a month to help teenager.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

United Patients Group

MAY 17, 2023

Some researchers believe that cannabinoids may help people with ASD manage anxiety and stress by increasing their ability to focus and pay attention. Cannabinoids have been shown to help people with autism manage anxiety and stress.

Sleep 78

Sleep Cannabinoids Patients CBD 78

Cannabis Life Network

MAY 5, 2019

The acquisition brings together Canopy Growth‘s medical business with Europe’s largest cannabinoid-based pharmaceuticals company. C3 is a leading manufacturer and distributor of dronabinol, a registered pharmaceutical drug in Germany, Austria, Switzerland, and Denmark.

Cannabinoids 44

Cannabinoids Pharmaceutical Patients Business 44

Cannabis Law Report

JUNE 1, 2022

(TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Europe and Latin America, announces that it has entered into an agreement to acquire Pharmadrug GmbH from its parent PharmaDrug Inc. CSE:PHRX) (OTC:LMLLF). This will have a direct positive impact on our revenues and higher gross margins.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

United Patients Group

FEBRUARY 2, 2023

Using Cannabis For Health and Wellness Introduction Cannabis is a plant that has been used for thousands of years to treat many ailments. The first recorded use of cannabis was in 2737 BC, when Emperor Shen Nung documented its value as a medicine. But what exactly is cannabis? This is where cannabis comes in!

Blood Pressure 103

Blood Pressure Sleep Chronic Pain Digestion 103

PrestoDoctor

DECEMBER 12, 2023

The Use of Cannabis Among Seniors More and more seniors are turning to cannabis as an alternative to traditional medications. As the stigma surrounding cannabis use decreases and more research shows the potential benefits, older adults are exploring this natural remedy for various ailments.

Medicine 98

Medicine Chronic Pain Consumption Pharmaceutical 98

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. billion 1 by 2025.

Access 105

Access Research and Development Pharmaceutical Therapy 105

FloridaMarijuana.net

JULY 6, 2018

As the rate of cancer diagnoses rises worldwide, patients are finding more options with their treatments and healthcare routines. Patients can suffer from the disease itself, or from the side effects of chemotherapy and other pharmaceuticals medications. This epidemic affects not only patients, but their families and caregivers.

Strains 189

Strains Indica Nerve Pain Hybrid 189

Greencamp

MAY 1, 2019

It took a lot of time for humanity to “rediscover” the medical potential of cannabis. Although there’s still a long way to go, cannabis has been accepted by many as a tool for treating regular nausea, but also nausea caused by chemotherapy. Nausea was actually one of the main reasons why medical cannabis became legal in some US states.

Patients 89

Patients Strains Sativa Marijuana 89

United Patients Group

APRIL 18, 2023

Introduction The medical cannabis industry is booming. However, there are still many myths about cannabis that persist despite being debunked by medical professionals and researchers alike. Myth: Cannabis is just a drug. Cannabis is a plant. Myth: Cannabis is a gateway to other drugs. Myth: Cannabis is a cure-all.

Research and Development 108

Research and Development Indica Treatment Conditions 108

Cannabis Law Report

AUGUST 29, 2021

This initial export to Brazil marks Avicanna ’s first commercial export of psychoactive Cannabis Extracts into the emerging Brazilian medicinal cannabis market and the delivery of the initial purchase order from the previously announced three (3) year master supply agreement.

Extraction 98

Extraction Supply Chain Research and Development CBD 98

Cannabis Law Report

DECEMBER 14, 2021

Pharmaceutical giant Pfizer Inc. is entering the cannabis space via the $6.7 billion acquisition of Arena Pharmaceuticals, Inc. Arena Pharmaceuticals, based in San Diego, Cal., is a biotech company with one segment of its drug pipeline dedicated to cannabinoid-type therapeutics. Read more at.

Research and Development 52

Research and Development Pharmaceutical Therapy Treatment 52

PrestoDoctor

SEPTEMBER 6, 2023

The legalization of cannabis in some countries and states has brought about significant changes in the healthcare industry. However, with the increasing popularity of cannabis, many people are turning to marijuana as a safer and better alternative for pain management.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

Veriheal

OCTOBER 13, 2020

Elevated levels of stress can even land these individuals in more discomfort, with IBD patients risking hospitalization due to inflammation. Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? What is IBS? What is the Difference Between IBD and IBS?

Digestion 120

Digestion Treatment Conditions Research and Development 120

FloridaMarijuana.net

AUGUST 15, 2018

Most commonly, patients report that tingling and numbness occur, usually in the hands and feet. Additionally, the ACPA reported on a clinical trial that suggests that inhaled cannabis may provide short-term relief from Neuropathy. For centuries, humans have relied on the cannabis plant for its therapeutic properties.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

Cannabis Law Report

JULY 7, 2021

A public cannabis company with a strong focus on the international market is stepping into Mexico’s nascent medical cannabis industry. In 2017, Mexico legalized medical cannabis with tetrahydrocannabinol (THC) concentrations below 1%. A lot of these countries are just beginning their cannabinoid journey.”.

Pharmaceutical 105

Pharmaceutical Cannabinoids Cultivation Concentrates 105

SpeedWeed

MARCH 13, 2021

Almost 25% of patients with Parkinson’s disease reported that they had used cannabis in the prior six months in a survey from the Parkinson’s Foundation. Parkinson’s disease patients typically use pharmaceutical medications to treat their condition with varying degrees of success. More Than 1,000 PD Patients Surveyed.

Patients 52

Patients Treatment Therapy Sleep 52

Canna Care Docs

JUNE 22, 2018

An Introductory Lesson on THC Basics For Medical Cannabis Patients. Cannabis, a plant that has proven to be endlessly complex is still under the microscope by researchers, patients, physicians, and society. Learning The THC Basics To Utilize It’s Many Therapeutic Benefits.

THC 66

THC Patients Blood Pressure Clinical Trials 66

Cannabis Law Report

JULY 29, 2021

This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. New progressive regulation on cannabis in Colombia. Initial shipment of THC extracts into the European Union.

Extraction 98

Extraction Supply Chain THC Research and Development 98

MGC Pharma

DECEMBER 12, 2017

A word from Elad Segev, Manager of Breeding and Cultivation at MGC Pharmaceuticals. A Cannabis plant is made up of 400 different chemicals that have physical and psychoactive effects when consumed together. Cannabinoids Many of the components found in Cannabis plants are known as cannabinoids.

Epilepsy 100

Epilepsy Cannabinoids Pharmaceutical THC 100

Cannabis Law Report

JULY 1, 2021

As Curaleaf International ‘s subsidiary Adven GmbH seeks to advance its medical cannabis products in Germany, it has teamed up with an Italian pharmaceutical company, Zambon Spa , with whom it will provide medical cannabis treatments for patients, with an initial focus on neurological therapies.

Treatment 93

Treatment Pharmaceutical Therapy Oil 93

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. InMed has conducted preclinical pharmacology studies that suggest CBN in INM-755 may help relieve hallmark EB symptoms, including inflammation and pain, as well potentially restore the integrity of the skin in a subset of EB Simplex patients. For more information, visit www.inmedpharma.com.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

APRIL 20, 2022

Growing demand in Poland for medical cannabis. WROCLAW, Poland , April 19, 2022 /PRNewswire/ — Can4Med , a licensed wholesale specializing in medical products containing THC and cannabinoids has obtained Polish authorization to supply medical products and raw materials for cannabis pharmaceutical sales.

Pharmaceutical 52

Pharmaceutical Patients Medicine Epilepsy 52